MediciNova Inc.

06/29/2022 | Press release | Distributed by Public on 06/29/2022 17:04

MediciNova Announces Extension of BARDA Contract to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury